| Name | Title | Contact Details |
|---|
MINT dentistry is the fastest growing privately-owned and innovative dental practice in the United States. We hire only the most talented artists – true Cosmetic Dentists – and then train them to Mint`s exacting standards. MINT dentists have been named “Best Dentist in Dallas,” and “Best Dentist in Houston” by the International Academy of Elite Cosmetic Dentistry the last two years, named “Best Family Dentists” by Consumer`s Choice the last two years, recognized by Living Magazine as “Outstanding Dentists”, recognized by Modern Luxury Dallas and Modern Luxury Houston as “Elite Doctors” and have garnered numerous other accolades from countless other sources. MINT dentistry took the industry over with our expertise in General and Cosmetic dentistry. The year after MINT opened, Dr. Harrison, the founder and CEO, invented a procedure to lengthen teeth in conjunction with veneers (lengthening teeth is needed for patients with short teeth, gingiva overgrowth, or smiles with too much gum showing). After revolutionizing Cosmetic Dentistry, we then reexamined every technique in General Dentistry, which is very technique sensitive. We questioned everything, and tried every material and technique on the market because we wanted our patients to have the best. As Mint grew, we focused on reducing complication rates. Most dental offices strive to achieve a 10% complication rate. Mint has succeeded in achieving a 1/1000th complication rate by developing the Mint Standards of Dentistry. These Standards specify our materials and our new techniques that we train dentists to use (it`s our secret sauce). Mint offers you dentists who work as a team (we invented this as well), extraordinary prices, and an insurance department that handles everything. Plus incredible payment plans and industry changing techniques. All this to be said you have to experience MINT dentistry to appreciate it, because it`s like nothing you`ve ever experienced.
Proximie is a technology platform that uses a combination of machine learning, artificial intelligence and augmented reality to allow clinicians to virtually scrub in and collaborate with each other from anywhere in the world.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
St Rose Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. St Rose Hospital is based in Hayward, CA. You can find more information on St Rose Hospital at www.strosehospital.org
CorEMR is a Midway, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.